PUBLICATIONS

Publications
  • Sanchez JS, Becker JA, Jacobs HIL, Hanseeuw BJ, Jiang S, Schultz AP, Properzi MJ, Katz SR, Beiser A, Satizabal CL, O’Donnell A, DeCarli C, Killiany R, El Fakhri G, Normandin MD, Gómez-Isla T, Quiroz YT, Rentz DM, Sperling RA, Seshadri S, Augustinack J, Price JC, Johnson KA. The cortical origin and initial spread of medial temporal tauopathy in Alzheimer’s disease assessed with positron emission tomography. Sci Transl Med. 2021 Jan 20;13(577):eabc0655.
  • Farrell ME, Jiang S, Schultz AP, Properzi MJ, Price JC, Becker JA, Jacobs HIL, Hanseeuw BJ, Rentz DM, Villemagne VL, Papp KV, Mormino EC, Betensky RA, Johnson KA, Sperling RA, Buckley RF. Defining the lowest threshold for amyloid-PET to predict future cognitive decline and amyloid accumulation.  Alzheimer’s disease Neuroimaging Initiative Harvard Aging Brain Study. Neurology. 2021 Jan 26;96(4):e619-e631.
  • Lois C, Sari H, Price JC. Kinetic Modelling and Parametric Imaging (Section 12). In:  Quantitative PET in the 2020s: A Roadmap. (Meikle SR, Sossi V, Roncali E, Cherry SR, et al.).  Phys Med Biol. 2021 Mar 12;66(6):06RM01
  • Rosas HD, Hsu E, Mercaldo ND, Lai F, Pulsifer M, Keator D, Brickman AM, Price J, Yassa M, Hom C, Krinsky-McHale SJ, Silverman W, Lott I, Schupf N. Alzheimer-related altered white matter microstructural integrity in Down syndrome:  A model for sporadic AD? Alzheimers Dement. 2020 Nov 7;12(1):e12040.
  • Hadjikhani N, Albrecht DS, Mainero C, Ichijo E, Ward N, Granziera C, Zürcher NR, Akeju O, Bonnier G, Price J, Hooker JM, Napadow V, Nahrendorf M, Loggia ML, Moskowitz MA. Extra-axial inflammatory signal in parameninges in migraine with visual aura. Ann Neurol. 2020 Apr 1. doi: 10.1002/ana.25731.
  • Buckley RF, Mormino EC, Rabin JS, Hohman TJ, Landau S, Hanseeuw BJ, Jacobs HIL, Papp KV, Amariglio RE, Properzi MJ, Schultz AP, Kirn D, Scott MR, Hedden T, Farrell M, Price J, Chhatwal J, Rentz DM, Villemagne VL, Johnson KA, Sperling RA. Sex Differences in the Association of Global Amyloid and Regional Tau Deposition Measured By Positron Emission Tomography in Clinically Normal Older Adults.   JAMA neurology. 2019;
  • Lois C, Gonzalez I, Johnson KA, Price JC. PET imaging of tau protein targets: a methodology perspective.  Brain Imaging Behav.  2019; 13 (2), 333-344.
  • Chen KT, Salcedo S, Chonde DB, Izquierdo-Garcia D, Levine MA, Price JC, Dickerson BC, Catana C. MR-assisted PET motion correction in simultaneous PET/MRI studies of dementia subjects.    J Magn Reson Imaging. 2018; 48(5):1288-1296.  

University of Pittsburgh, University of Wisconsin, University of California – Berkeley

  • Williams KV, Shay CM, Price JC, Goodpaster BH, Kelley CA, Kelley DE, Orchard TJ. Muscle insulin resistance in type 1 diabetes with coronary artery disease. 2020 Dec;63(12):2665-2674
  • Larsen B, Olafsson V, Calabro F, Laymon C, Tervo-Clemmens B, Campbell E, Minhas. D, Montez D, Price J, Luna B. Maturation of the human striatal dopamine system revealed by PET and quantitative MRI.  Nature Communications. 2020; 12;11(1):846. 
  • Tudorascu DL, Anderson SJ, Minhas DS, Yu Z, Comer D, Lao P, Hartley S, Laymon CM, Snitz BE, Lopresti BJ, Johnson S, Price JC, Mathis CA, Aizenstein HJ, Klunk WE, Handen BL, Christian BT, Cohen AD. Comparison of longitudinal Aβ in nondemented elderly and Down syndrome.  Neurobiol Aging 2019; 73:171-176.
  • Lao PJ, Handen BL, Betthauser TJ, Cody KA, Cohen AD, Tudorascu DL, Stone CK, Price JC, Johnson SC, Klunk WE, Christian BT.  Imaging neurodegeneration in Down syndrome:  brain templates for amyloid burden and tissue segmentation. Brain Imaging Behav. 2019 Apr;13(2):345-353
  • Wilckens KA, Tudorascu DL, Snitz BE, Price JC, Aizenstein HJ, Lopez OL, Erickson KI, Lopresti BJ, Laymon CM, Minhas D, Mathis CA, Buysse DJ, Klunk WE, Cohen AD.  Sleep moderates the relationship between amyloid beta and memory recall.   Neurobiol Aging. 2018 Nov;71:142-148.
  • Laymon CM, Minhas DS, Becker CR, Matan C, Oborski MJ, Price JC, Mountz JM.   Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging. Mol Imaging Biol. 2018 Oct;20(5):826-834
  • Cohen AD, McDade E, Christian B, Price J, Mathis C, Klunk W, Handen BL.  Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer’s disease from late-onset amyloid deposition.  Alzheimers Dement. 2018 14(6):743-750.
  • Minhas DS, Price JC, Laymon CM, Becker CR, Klunk WE, Tudorascu DL, Abrahamson EE, Hamilton RL, Kofler JK, Mathis CA, Lopez OL, Ikonomovic MD. Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of Aβ load. Neuroimage Clin. 2018 19:182-189.
  • Lao PJ, Handen BL, Betthauser TJ, Mihaila I, Hartley SL, Cohen AD, Tudorascu DL, Bulova PD, Lopresti BJ, Tumuluru RV, Murali D, Mathis CA, Barnhart TE, Stone CK, Price JC, Devenny DA, Johnson SC, Klunk WE, Christian BT.   Alzheimer-Like Pattern of Hypometabolism Emerges with Elevated Amyloid-β Burden in Down Syndrome. J Alzheimers Dis. 2018;61(2):631-644. 
  • Zhao Y, Tudorascu DL, Lopez OL, Cohen AD, Mathis CA, Aizenstein HJ, Price JC, Kuller LH, Kamboh MI, DeKosky ST, Klunk WE, Snitz BE. Amyloid β Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia.  JAMA Neurol. 2018 Jan 1;75(1):88-96.  
  • Baker SL, Lockhart SN, Price JC, He M, Huesman RH, Schonhaut D, Faria J, Rabinovici G, Jagust WJ.   Reference tissue-based kinetic evaluation of 18F-AV-1451 in aging and dementia. J Nuclear Med. 2017; 58(2):332-338.

In Collaboration With: 

Screen Shot 2021 06 04 at 1.02.36 PM

Contact

Athinoula A. Martinos Center

149 13th Street, Charlestown, MA 02129, United States

Email: pricelab@mgh.harvard.edu

resize